Market/Novel Tech Articles
UK researchers highlight negative consequences of Brexit for the development of and access to medicines for orphan (rare) diseases in paediatrics.
UK researchers in Queens University Belfast (QUB) have published an article on the implications of a “no deal” Brexit for orphan and paediatric medicines. The research, published in the British Medical Journal (BMJ), stressed that the impending exit of the UK from the EU “would have considerable adverse consequences on pharmaceutical research and development and […]Read full story
A private company, China Ophthalmology Focus Ltd, is set to focus on the ophthalmic Asia market.
A private company, China Ophthalmology Focus Ltd., founded in 2018 and located in Honk Kong has recently raised $50 million in a series A round for the ophthalmic Asian market. The company has outlined that 21 research and development programs are in progress, including 9 innovative compounds and 12 generics that span dry eye diseases, […]Read full story
Regeneron Pharmaceuticals Inc. announces the 2019 winners of the “Regeneron Prize for Creative Innovation”
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the winners of the seventh annual Regeneron Prize for Creative Innovation. The country’s leading research universities were asked to nominate top candidates for the Regeneron Prize in the ‘graduate student’ and ‘postdoctoral fellow’ categories. In total $155,000 in prize money and donations was awarded to finalists, winners and institutions. […]Read full story